7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Global Cardiovascular Challenges
Cardiovascular diseases (CVD) are responsible for a substantial portion of global health issues, with rising numbers of cases in both developed and developing nations. The challenges associated with CVD are multifaceted, involving a complex interplay of genetic, environmental, and socioeconomic factors. In many regions, limited access to quality healthcare and the increasing prevalence of risk factors like obesity, diabetes, and smoking contribute to the growing burden of heart disease. Tackling these global cardiovascular challenges demands innovative public health strategies that emphasize prevention, equitable access to care, and the education of populations about the importance of lifestyle modifications. Efforts at a global level to address these issues will play a key role in reducing the impact of CVD on health systems worldwide.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Steve Cohen
Medvesta Hypnosis Healthcare, NSA Illinois, United States
Ruth Rasmussen
Liberty University, United States
Franz Porzsolt
Private Research Institute Clinical Economics, GermanySubmit your abstract Today
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Implantation of permanent cardiac pacemakers with right-sided access in collaboration with a vascular surgeon: pro et contra
Davor Horvat, General Hospital, , Croatia (Hrvatska)
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension
Panpan Hao, Department of Cardiology, Qilu Hospital, Shandong University, Jinan, Shandong, China